https://www.selleckchem.com/products/2-d08.html
On the basis of Kaplan-Meier survival analysis between high Apo A1 subgroup and low Apo A1 subgroup, we found higher Apo A1 patienta had longer OS rate and PFS. Conclusions Apo A1 is a useful biomarker of tumor burden and a prognostic factor of multiple myeloma.Objective To evaluate the efficacy and safety of iron supplement in patients who have paroxysmal nocturnal hemoglobinuria (PNH) with iron deficiency. Methods We performed analyses on the clinical data of 48 patients who accepted oral and/or intravenous iron treatment. Forty-eight c
Like
Comment
Share
